$21.30 0.25 (+1.19%)
2/13/2012 4:00 PM

Pfizer, Inc. (NYSE:PFE)

CAPS Rating: 4 out of 5

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.

Recs

0
Player Avatar TDRH (99.92) Submitted: 9/29/2008 11:14:20 PM : Outperform Start Price: $17.93 PFE Score: +10.01

Yes the pipleine is dry, yes it was a value trap when I bought it at $23.50, but the 6.9% dividend yield should keep this one from falling further and could preserve capital. Still positive cash flow and AAA rating, does not need to borrow money for operations, still feeding of the cash cows near expiry.

Report this Post Add Comment

Featured Broker Partners


Advertisement